Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat containing protein 63 (LRRC63) is a member of the LRR-containing protein superfamily, characterized by repetitive leucine-rich motifs that form a structural framework for protein-protein interactions[1][2]. The LRR protein family consists of hundreds of distinct members in humans, many of which play important roles in immunity, cell signaling, and neural development. While some LRR proteins are well-studied (such as Toll-like receptors and NOD-like receptors), LRRC63 itself remains poorly characterized. Its structure likely includes canonical LRR motifs essential for binding interactions, but its specific functional significance, associated pathways, and disease relevance have not been defined in peer-reviewed literature or functional protein annotation sources[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat containing protein 63 (LRRC63).